These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8086138)

  • 1. Relationship between body weight, body surface area and serum zidovudine pharmacokinetic parameters in adult, male HIV-infected patients.
    Sahai J; Gallicano K; Ormsby E; Garber G; Cameron DW
    AIDS; 1994 Jun; 8(6):793-6. PubMed ID: 8086138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic variability of zidovudine in HIV-infected individuals: subgroup analysis and drug interactions.
    Burger DM; Meenhorst PL; ten Napel CH; Mulder JW; Neef C; Koks CH; Bult A; Beijnen JH
    AIDS; 1994 Dec; 8(12):1683-9. PubMed ID: 7888117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of saquinavir, zidovudine, and zalcitabine in combination therapy.
    Vanhove GF; Kastrissios H; Gries JM; Verotta D; Park K; Collier AC; Squires K; Sheiner LB; Blaschke TF
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2428-32. PubMed ID: 9371345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of orally administered zidovudine in HIV-infected children and adults.
    Wintergerst U; Rolinski B; Vocks-Hauck M; Wahn V; Debatin KM; Notheis G; Grosch-Wörner I; Goebel FD; Roscher AA; Belohradsky BH
    Infection; 1995; 23(6):344-8. PubMed ID: 8655204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic evaluations of low- and high-dose zidovudine plus high-dose acyclovir in patients with symptomatic human immunodeficiency virus infection.
    Tartaglione TA; Collier AC; Opheim K; Gianola FG; Benedetti J; Corey L
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2225-31. PubMed ID: 1803995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of zidovudine after the initial single dose and during chronic-dose therapy in HIV-infected patients.
    Gallicano K; Sahai J; Ormsby E; Cameron DW; Pakuts A; McGilveray I
    Br J Clin Pharmacol; 1993 Aug; 36(2):128-31. PubMed ID: 8398581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and bioavailability of zidovudine and its glucuronidated metabolite in patients with human immunodeficiency virus infection and hepatic disease (AIDS Clinical Trials Group protocol 062).
    Moore KH; Raasch RH; Brouwer KL; Opheim K; Cheeseman SH; Eyster E; Lemon SM; van der Horst CM
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2732-7. PubMed ID: 8593010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in children with HIV infection.
    Gibb D; Barry M; Ormesher S; Nokes L; Seefried M; Giaquinto C; Back D
    Br J Clin Pharmacol; 1995 May; 39(5):527-30. PubMed ID: 7669489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlates of zidovudine phosphorylation with markers of HIV disease progression and drug toxicity.
    Stretcher BN; Pesce AJ; Frame PT; Greenberg KA; Stein DS
    AIDS; 1994 Jun; 8(6):763-9. PubMed ID: 8086134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetics of zidovudine and its toxic catabolite 3'-amino-3'-deoxythymidine in HIV-infected patients.
    Zhou XJ; Sommadossi JP
    AIDS Res Hum Retroviruses; 1996 Feb; 12(3):229-33. PubMed ID: 8835201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the in vivo effect of naproxen on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus.
    Sahai J; Gallicano K; Garber G; Pakuts A; Hawley-Foss N; Huang L; McGilveray I; Cameron DW
    Clin Pharmacol Ther; 1992 Nov; 52(5):464-70. PubMed ID: 1424420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative bioavailability study of zidovudine administered as two different tablet formulations in healthy adult subjects.
    Marier JF; Manthos H; Kebir S; Ferron S; DiMarco M; Morelli G; Tippabhotla SK; Vijan T; Singla AK; Garg M; Monif T
    Int J Clin Pharmacol Ther; 2006 May; 44(5):240-6. PubMed ID: 16724579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once-daily dosing of saquinavir and low-dose ritonavir in HIV-1-infected individuals: a pharmacokinetic pilot study.
    van Heeswijk RP; Veldkamp AI; Mulder JW; Meenhorst PL; Lange JM; Beijnen JH; Hoetelmans RM
    AIDS; 2000 Jun; 14(9):F103-10. PubMed ID: 10894270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic interaction of megestrol acetate with zidovudine in human immunodeficiency virus-infected patients.
    Van Harken DR; Pei JC; Wagner J; Pike IM
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2480-3. PubMed ID: 9371353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of zidovudine glucuronidation and amination pathways by rifampicin in HIV-infected patients.
    Gallicano KD; Sahai J; Shukla VK; Seguin I; Pakuts A; Kwok D; Foster BC; Cameron DW
    Br J Clin Pharmacol; 1999 Aug; 48(2):168-79. PubMed ID: 10417493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of zidovudine alone and in combination with oxazepam in the HIV infected patient.
    Mole L; Israelski D; Bubp J; O'Hanley P; Merigan T; Blaschke T
    J Acquir Immune Defic Syndr (1988); 1993 Jan; 6(1):56-60. PubMed ID: 8417175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between exposure to zidovudine and decrease of P24 antigenemia in HIV-infected patients in monotherapy.
    Sasomsin P; Mentré F; Diquet B; Simon F; Brun-Vezinet F
    Fundam Clin Pharmacol; 2002 Oct; 16(5):347-52. PubMed ID: 12602459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zidovudine triphosphate and lamivudine triphosphate concentration-response relationships in HIV-infected persons.
    Fletcher CV; Kawle SP; Kakuda TN; Anderson PL; Weller D; Bushman LR; Brundage RC; Remmel RP
    AIDS; 2000 Sep; 14(14):2137-44. PubMed ID: 11061655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semen and serum pharmacokinetics of zidovudine and zidovudine-glucuronide in men with HIV-1 infection.
    Anderson PL; Noormohamed SE; Henry K; Brundage RC; Balfour HH; Fletcher CV
    Pharmacotherapy; 2000 Aug; 20(8):917-22. PubMed ID: 10939552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic disposition of zidovudine during pregnancy.
    Watts DH; Brown ZA; Tartaglione T; Burchett SK; Opheim K; Coombs R; Corey L
    J Infect Dis; 1991 Feb; 163(2):226-32. PubMed ID: 1988507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.